{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:25:17Z","timestamp":1782962717117,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,5,4]],"date-time":"2013-05-04T00:00:00Z","timestamp":1367625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s11011-013-9406-2","type":"journal-article","created":{"date-parts":[[2013,5,3]],"date-time":"2013-05-03T07:52:29Z","timestamp":1367567549000},"page":"597-604","source":"Crossref","is-referenced-by-count":16,"title":["Association between the characteristics of metabolic syndrome and Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"28","author":[{"given":"Hui-Ting","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jing","family":"Sheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuen-Der","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-An","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Chun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiann-Liang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,4]]},"reference":[{"key":"9406_CR1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/rej.2011.1289","volume":"15","author":"G Accardi","year":"2012","unstructured":"Accardi G, Caruso C, Colonna-Romano G, Camarda C, Monastero R, Candore G (2012) Can Alzheimer disease be a form of type 3 diabetes? Rejuvenation Res 15:217\u2013221","journal-title":"Rejuvenation Res"},{"key":"9406_CR2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2174\/157015911798376334","volume":"9","author":"L Arab","year":"2011","unstructured":"Arab L, Sadeghi R, Walker DG, Lue LF, Sabbagh MN (2011) Consequences of aberrant insulin regulation in the brain: can treating diabetes be effective for Alzheimer\u2019s disease. Curr Neuropharmacol 9:693\u2013705","journal-title":"Curr Neuropharmacol"},{"key":"9406_CR3","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1212\/01.WNL.0000137040.64252.ED","volume":"63","author":"A Assini","year":"2004","unstructured":"Assini A, Cammarata S, Vitali A, Colucci M, Giliberto L, Borghi R, Inglese ML, Volpe S, Ratto S, Dagna-Bricarelli F, Baldo C, Argusti A, Odetti P, Piccini A, Tabaton M (2004) Plasma levels of amyloid beta-protein 42 are increased in women with mild cognitive impairment. Neurology 63:828\u2013831","journal-title":"Neurology"},{"key":"9406_CR4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0090-6980(02)00031-X","volume":"68\u201369","author":"NG Bazan","year":"2002","unstructured":"Bazan NG, Colangelo V, Lukiw WJ (2002) Prostaglandins and other lipid mediators in Alzheimer\u2019s disease. Prostaglandins Other Lipid Mediat 68\u201369:197\u2013210","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"9406_CR5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.nbd.2006.06.007","volume":"24","author":"BL Burgess","year":"2006","unstructured":"Burgess BL, McIsaac SA, Naus KE, Chan JY, Tansley GH, Yang J, Miao F, Ross CJ, van Eck M, Hayden MR, van Nostrand W, St George-Hyslop P, Westaway D, Wellington CL (2006) Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer\u2019s disease mouse models with abundant A beta in plasma. Neurobiol Dis 24:114\u2013127","journal-title":"Neurobiol Dis"},{"key":"9406_CR6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9440(10)63822-9","volume":"162","author":"DG Cook","year":"2003","unstructured":"Cook DG, Leverenz JB, McMillan PJ, Kulstad JJ, Ericksen S, Roth RA, Schellenberg GD, Jin LW, Kovacina KS, Craft S (2003) Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer\u2019s disease is associated with the apolipoprotein E-epsilon4 allele. Am J Pathol 162:313\u2013319","journal-title":"Am J Pathol"},{"key":"9406_CR7","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.neubiorev.2011.03.001","volume":"35","author":"LA Craig","year":"2011","unstructured":"Craig LA, Hong NS, McDonald RJ (2011) Revisiting the cholinergic hypothesis in the development of Alzheimer\u2019s disease. Neurosci Biobehav Rev 35:1397\u20131409","journal-title":"Neurosci Biobehav Rev"},{"key":"9406_CR8","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/j.1471-4159.2006.03931.x","volume":"98","author":"C d\u2019Abramo","year":"2006","unstructured":"d\u2019Abramo C, Ricciarelli R, Pronzato MA, Davies P (2006) Troglitazone, a peroxisome proliferator-activated receptor-gamma agonist, decreases tau phosphorylation in CHOtau4R cells. J Neurochem 98:1068\u20131077","journal-title":"J Neurochem"},{"key":"9406_CR9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/JAD-2006-10113","volume":"10","author":"SM Monte de la","year":"2006","unstructured":"de la Monte SM, Tong M, Lester-Coll N, Plater M Jr, Wands JR (2006) Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer\u2019s disease. J Alzheimers Dis 10:89\u2013109","journal-title":"J Alzheimers Dis"},{"key":"9406_CR10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0149-7634(94)90052-3","volume":"18","author":"JC Torre de la","year":"1994","unstructured":"de la Torre JC (1994) Impaired brain microcirculation may trigger Alzheimer\u2019s disease. Neurosci Biobehav Rev 18:397\u2013401","journal-title":"Neurosci Biobehav Rev"},{"key":"9406_CR11","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","volume":"100","author":"W Farris","year":"2003","unstructured":"Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guenette S (2003) Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci U S A 100:4162\u20134167","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9406_CR12","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1001\/archneur.60.7.958","volume":"60","author":"H Fukumoto","year":"2003","unstructured":"Fukumoto H, Tennis M, Locascio JJ, Hyman BT, Growdon JH, Irizarry MC (2003) Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels. Arch Neurol 60:958\u2013964","journal-title":"Arch Neurol"},{"key":"9406_CR13","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1734-1140(11)70611-9","volume":"63","author":"BR Goyal","year":"2011","unstructured":"Goyal BR, Parmar K, Goyal RK, Mehta AA (2011) Beneficial role of telmisartan on cardiovascular complications associated with STZ-induced type 2 diabetes in rats. Pharmacol Rep 63:956\u2013966","journal-title":"Pharmacol Rep"},{"key":"9406_CR14","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s11745-001-0843-0","volume":"36","author":"SJ Iverson","year":"2001","unstructured":"Iverson SJ, Lang SL, Cooper MH (2001) Comparison of the Bligh and Dyer and Folch methods for total lipid determination in a broad range of marine tissue. Lipids 36:1283\u20131287","journal-title":"Lipids"},{"key":"9406_CR15","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S1474-4422(08)70169-8","volume":"7","author":"RN Kalaria","year":"2008","unstructured":"Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K, Luchsinger JA, Ogunniyi A, Perry EK, Potocnik F, Prince M, Stewart R, Wimo A, Zhang ZX, Antuono P (2008) Alzheimer\u2019s disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol 7:812\u2013826","journal-title":"Lancet Neurol"},{"key":"9406_CR16","first-page":"373","volume":"14","author":"Z Kroner","year":"2009","unstructured":"Kroner Z (2009) The relationship between Alzheimer\u2019s disease and diabetes: type 3 diabetes? Altern Med Rev 14:373\u2013379","journal-title":"Altern Med Rev"},{"key":"9406_CR17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1159\/000235555","volume":"90","author":"YH Lee","year":"2009","unstructured":"Lee YH, Martin JM, Maple RL, Tharp WG, Pratley RE (2009) Plasma amyloid-beta peptide levels correlate with adipocyte amyloid precursor protein gene expression in obese individuals. Neuroendocrinology 90:383\u2013390","journal-title":"Neuroendocrinology"},{"key":"9406_CR18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JAD-2006-9102","volume":"9","author":"N Lester-Coll","year":"2006","unstructured":"Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, de la Monte SM (2006) Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer\u2019s disease. J Alzheimers Dis 9:13\u201333","journal-title":"J Alzheimers Dis"},{"key":"9406_CR19","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/archneur.65.6.776","volume":"65","author":"JJ Locascio","year":"2008","unstructured":"Locascio JJ, Fukumoto H, Yap L, Bottiglieri T, Growdon JH, Hyman BT, Irizarry MC (2008) Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease. Arch Neurol 65:776\u2013785","journal-title":"Arch Neurol"},{"key":"9406_CR20","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/brain\/awq376","volume":"134","author":"J Lu","year":"2011","unstructured":"Lu J, Wu DM, Zheng ZH, Zheng YL, Hu B, Zhang ZF (2011) Troxerutin protects against high cholesterol-induced cognitive deficits in mice. Brain 134:783\u2013797","journal-title":"Brain"},{"key":"9406_CR21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0003-2697(78)90342-1","volume":"86","author":"M Mihara","year":"1978","unstructured":"Mihara M, Uchiyama M (1978) Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86:271\u2013278","journal-title":"Anal Biochem"},{"key":"9406_CR22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jalz.2010.03.017","volume":"6","author":"JA Mortimer","year":"2010","unstructured":"Mortimer JA, Borenstein AR, Ding D, Decarli C, Zhao Q, Copenhaver C, Guo Q, Chu S, Galasko D, Salmon DP, Dai Q, Wu Y, Petersen R, Hong Z (2010) High normal fasting blood glucose is associated with dementia in Chinese elderly. Alzheimers Dement 6:440\u2013447","journal-title":"Alzheimers Dement"},{"key":"9406_CR23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3988\/jcn.2011.7.1.10","volume":"7","author":"SA Park","year":"2011","unstructured":"Park SA (2011) A common pathogenic mechanism linking type-2 diabetes and Alzheimer\u2019s disease: evidence from animal models. J Clin Neurol 7:10\u201318","journal-title":"J Clin Neurol"},{"key":"9406_CR24","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1194\/jlr.R300007-JLR200","volume":"44","author":"RL Raffai","year":"2003","unstructured":"Raffai RL, Weisgraber KH (2003) Cholesterol: from heart attacks to Alzheimer\u2019s disease. J Lipid Res 44:1423\u20131430","journal-title":"J Lipid Res"},{"key":"9406_CR25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2337\/dc08-0272","volume":"32","author":"C Raffaitin","year":"2009","unstructured":"Raffaitin C, Gin H, Empana JP, Helmer C, Berr C, Tzourio C, Portet F, Dartigues JF, Alperovitch A, Barberger-Gateau P (2009) Metabolic syndrome and risk for incident Alzheimer\u2019s disease or vascular dementia: the Three-City Study. Diabetes Care 32:169\u2013174","journal-title":"Diabetes Care"},{"issue":"Suppl 3","key":"9406_CR26","first-page":"10","volume":"16","author":"P Sankar","year":"2012","unstructured":"Sankar P, Subhashree S, Sudharani S (2012) Effect of Trigonella foenum-graecum seed powder on the antioxidant levels of high fat diet and low dose streptozotocin induced type II diabetic rats. Eur Rev Med Pharmacol Sci 16(Suppl 3):10\u201317","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"9406_CR27","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/jnr.22603","volume":"89","author":"JG Sutcliffe","year":"2011","unstructured":"Sutcliffe JG, Hedlund PB, Thomas EA, Bloom FE, Hilbush BS (2011) Peripheral reduction of beta-amyloid is sufficient to reduce brain beta-amyloid: implications for Alzheimer\u2019s disease. J Neurosci Res 89:808\u2013814","journal-title":"J Neurosci Res"},{"key":"9406_CR28","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1124\/mol.107.036913","volume":"72","author":"C Tamaki","year":"2007","unstructured":"Tamaki C, Ohtsuki S, Terasaki T (2007) Insulin facilitates the hepatic clearance of plasma amyloid beta-peptide (1 40) by intracellular translocation of low-density lipoprotein receptor-related protein 1 (LRP-1) to the plasma membrane in hepatocytes. Mol Pharmacol 72:850\u2013855","journal-title":"Mol Pharmacol"},{"key":"9406_CR29","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1474-4422(06)70501-4","volume":"5","author":"M Oijen van","year":"2006","unstructured":"van Oijen M, Hofman A, Soares HD, Koudstaal PJ, Breteler MM (2006) Plasma Abeta(1\u201340) and Abeta(1\u201342) and the risk of dementia: a prospective case-cohort study. Lancet Neurol 5:655\u2013660","journal-title":"Lancet Neurol"},{"key":"9406_CR30","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1212\/01.wnl.0000234037.91185.99","volume":"67","author":"M Vanhanen","year":"2006","unstructured":"Vanhanen M, Koivisto K, Moilanen L, Helkala EL, Hanninen T, Soininen H, Kervinen K, Kesaniemi YA, Laakso M, Kuusisto J (2006) Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology 67:843\u2013847","journal-title":"Neurology"},{"key":"9406_CR31","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s10620-009-0815-3","volume":"55","author":"ZJ Xu","year":"2010","unstructured":"Xu ZJ, Fan JG, Ding XD, Qiao L, Wang GL (2010) Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats. Dig Dis Sci 55:931\u2013940","journal-title":"Dig Dis Sci"},{"key":"9406_CR32","doi-asserted-by":"crossref","first-page":"704045","DOI":"10.1155\/2008\/704045","volume":"2008","author":"M Zhang","year":"2008","unstructured":"Zhang M, Lv XY, Li J, Xu ZG, Chen L (2008) The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Exp Diabetes Res 2008:704045","journal-title":"Exp Diabetes Res"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-013-9406-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-013-9406-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-013-9406-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T02:21:56Z","timestamp":1559355716000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-013-9406-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["9406"],"URL":"https:\/\/doi.org\/10.1007\/s11011-013-9406-2","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,4]]}}}